In addition, as was previously reported, we observed an increase in the expression of SOD2, which is known to be involved in the mitochondrial oxidative stress pathway 14
Furthermore, combination therapy trials exploring the synergistic effects of GLP-1RAs with biologics could uncover new approaches for treatment, enhancing the management both metabolic and immunologic aspects in PsA
The market is growing due to increasing diabetes prevalence and government healthcare initiatives aimed at improving access to treatments
C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease
The goal is to bypass the usual insurance hurdles, making it easier for patients to access the care they need
Non response to B12 injections should therefore necessitate re-evaluation and consideration of other diagnoses